1. Arvind Fashions:
Anand Rathi maintains a ‘Buy’ rating on this apparel company with a target price of Rs 681, indicating an upside of 50.6%. The company's share price has taken a hit recently, declining by 20.7% over the past six months. Arvind Fashions markets and distributes branded apparel and accessories, and reported a net loss of Rs 93.2 crore in Q4FY25, against a profit of Rs 24.3 crore in Q4FY24. The loss was mainly due to a one-time deferred tax charge of Rs 1,200 crore, following a shift in its subsidiary Arvind Lifestyle Brands’ tax rate from 35% to 25%.
Looking past that figure, all five core brands (US Polo, Tommy Hilfiger, etc.) posted double-digit revenue growth in Q4, with most also delivering double-digit EBITDA growth. For the full year, the company reported 8.5% revenue growth and a 100 bps improvement in its EBITDA margin. This performance was supported by premiumization and a shift toward stronger, well-established brands.
Analyst Vaishnavi Mandhaniya finds initial FY26 trends encouraging, noting improved comparable growth (same-store sales) in the first 45 days. She expects supportive macro conditions and tax cuts to drive growth above 5% in FY26 (5.5% in FY25).
The company’s management maintains its guidance of 12-15% revenue growth in FY26, supported by a recovery in the wholesale channel and steady growth in the retail channel.
2. Karur Vysya Bank:
Emkay reiterates its ‘Buy’ rating on this bank with a target price of Rs 300, a 32.3% upside. In Q4FY25, the bank’s gross NPA ratio improved by 64 bps YoY to 0.8%, supported by lower slippages, higher write-offs, and better recoveries. Net NPAs stood at 0.2%. Analysts Anand Dama, Nikhil Vaishnav, and Kunaal N note this is among the lowest NPAs in its peer group, including City Union, Ujjivan, and Equitas SFB. The bank features in a screener of stocks with good Trendlyne valuation scores.
The management expects gross NPAs to stay below 1% and net NPAs of around 0.5% in FY26, with slippages likely to remain under 1%. Net interest margin (NIM) was broadly stable at 4.1% due to a shift toward higher-yielding, secured retail loans. However, the bank expects margins to moderate to 3.7–3.75%, in line with possible policy rate cuts.
For FY25, the bank’s net profit rose 21% to Rs 1,942 crore, while revenue grew 16.7% driven by higher interest income and investment earnings. Dama and team expect the bank to deliver a return on equity (RoE) of 16–18%, supported by strong asset quality, healthy capital and provision buffers, and stable management.
3. Bharat Electronics:
ICICI Securities maintains its ‘Buy’ rating on this defence company and raises the target price to Rs 420, indicating an upside of 8.9%. In Q4FY25, the company’s revenue grew 6.8% YoY to Rs 9,149 crore and net profit rose 18.4% to Rs 2,127 crore, helped by high-margin orders and improved execution.
For FY25, revenue grew 15% and net profit rose 33.4%, driven by an increase in new orders. The company's management expects an order inflow of over Rs 57,000 crore over the next 12–13 months, driven by emergency procurement orders from the Ministry of Defence and export demand.
Analysts Amit Dixit and Mohit Lohia remain optimistic about Bharat Electronics’ software-defined radios (SDRs) segment for naval programmes. They expect BEL to secure 85% of the upcoming SDR orders from the Indian Navy, with a potential order book of Rs 8,000–10,000 crore.
BEL targets a 15% revenue CAGR and 20% profit CAGR over the next 3–4 years. Analysts also remain positive about the company’s growth prospects beyond defence. They expect order book execution to remain strong, backed by healthy margins over the next 2–3 years.
4. Transport Corp of India:
Sharekhan maintains a ‘Buy’ rating on this logistics solutions player with a target price of Rs 1,350, implying a 18% upside. In FY25, the company’s revenue rose 11.6% YoY to Rs 4,491.8 crore, led by the supply chain management (SCM) segment. Growth in SCM was supported by new contracts and expansion in the warehousing, quick commerce, and automotive sectors. Its net profit increased by 16.8% during the year.
Transport Corporation’s management expects 10–12% growth in revenue and profit for FY26. The SCM segment is projected to grow 12–15% and remain the key revenue driver. Analysts note the company’s plans to invest Rs 400–450 crore in FY26 to expand infrastructure, including ships, trucks, and warehouses.
Analysts believe the company is well-positioned to benefit from the Centre’s AtmaNirbhar Bharat push and global supply chain shifts. They estimate revenue and net profit to grow by 12.4% and 15.4%, respectively, over FY26–27.
5. Sun Pharmaceuticals:
Motilal Oswal maintains a ‘Buy’ rating on this pharma company with a target price of Rs 2,000, an upside of 18.8%. In Q4FY25, the company’s revenue grew 8.2% YoY to Rs 12,958 crore but missed estimates by 4% due to lower-than-expected sales in global specialty drugs and rest of the world (ROW) markets. Net profit also missed estimates by 4% due to higher litigation expenses and restructuring of US operations.
During the quarter, the company launched 10 new products across multiple therapy areas, such as pain management and anti-diabetics. These launches are expected to drive an 11% sales CAGR in the DF segment by FY27. Analyst Tushar Manudhane expects Sun Pharma to outperform the industry in India’s domestic formulation (DF) market due to new product launches and strong growth in existing brands.
For FY25, the company's revenue grew 9.4% and net profit rose 14.4%. The management aims to achieve mid-to-high single-digit revenue growth in FY26, supported by new specialty product launches in 2025.
The company plans to invest Rs 830 crore in FY26 towards promotional activities and research and development (R&D) expansion for its specialty portfolio. The analysts project the company’s net profit to grow at a CAGR of 17% over FY26–27.
Note: These recommendations are from various analysts and are not recommendations by Trendlyne.
(You can find all analyst picks here)
